Recruiting Asthma Studies in Huntington Beach
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
The primary objective of the study is to assess the efficacy of high dose and low dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic module multidose dry powder inhaler (eM...
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to standard of care therapy on preventing or slowing ...
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are...
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolle...
A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations
A dose range-finding study to assess the efficacy and safety of multiple dose levels of AZD8630 administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, recei...
A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed replacement propellant HFO compared with BDA delivered using the...
A Study to Evaluate Solriktug in Adult Participants With Asthma
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma....
About Asthma Clinical Trials in Huntington Beach
Asthma is a chronic respiratory condition where the airways become inflamed and narrow, causing difficulty breathing, wheezing, and coughing. It affects over 300 million people worldwide. Treatment includes inhaled corticosteroids, bronchodilators, and biologics for severe asthma.
There are currently 7 asthma clinical trials recruiting participants in Huntington Beach, CALIFORNIA. These studies are seeking a combined 5,822 participants. Research is being sponsored by Teva Branded Pharmaceutical Products R&D, Inc., Sanofi, AstraZeneca and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Asthma Clinical Trials in Huntington Beach — FAQ
Are there asthma clinical trials in Huntington Beach?
Yes, there are 7 asthma clinical trials currently recruiting in Huntington Beach, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Huntington Beach?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntington Beach research site will contact you about next steps.
Are clinical trials in Huntington Beach free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Huntington Beach studies also compensate for your time and travel.
What asthma treatments are being tested?
The 7 active trials in Huntington Beach are testing new therapies including novel drugs, biologics, and treatment approaches for asthma.
Data updated March 2, 2026 from ClinicalTrials.gov